Guided Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $7.2M | $2.2M | $725.0K |
| Jun 2022 | $7.3M | $1.5M | $446.0K |
| Sep 2022 | $6.5M | $3.9M | $2.7M |
| Dec 2022 | $6.2M | $3.4M | $2.3M |
| Mar 2023 | $5.7M | $2.9M | $1.8M |
| Jun 2023 | $5.7M | $2.3M | $1.4M |
| Sep 2023 | $5.5M | $1.9M | $731.0K |
| Dec 2023 | $5.5M | $1.7M | $591.0K |
| Mar 2024 | $5.5M | $1.5M | $445.0K |
| Jun 2024 | $5.9M | $1.3M | $275.0K |
| Sep 2024 | $6.2M | $1.2M | $194.0K |
| Dec 2024 | $6.3M | $1.4M | $388.0K |
| Mar 2025 | $6.0M | $967.0K | $115.0K |
| Jun 2025 | $6.4M | $940.0K | $185.0K |
| Sep 2025 | $6.5M | $903.0K | $87.0K |
| Dec 2025 | $7.3M | $1.3M | $63.0K |
| Mar 2026 | $6.8M | $1.6M | $369.0K |
| Jun 2026 | $7.0M | $1.2M | $12.0K |